Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
70.8 SEK | +1.14% | -1.39% | +14.56% |
May. 14 | Bactiguard Holding Ab Appoints Thomas Von Koch as the Chairman of the Board of Directors | CI |
Apr. 25 | Transcript : Bactiguard Holding AB, Q1 2024 Earnings Call, Apr 25, 2024 |
Summary
- Overall, the company has poor fundamentals for a medium to long-term investment strategy.
Strengths
- Over the last 4 months, analysts have significantly revised upwards the company's estimated sales.
- For the last 4 months, the company has been enjoying highly positive EPS revisions, which were frequently and significantly raised.
Weaknesses
- Low profitability weakens the company.
- One of the major weak points of the company is its financial situation.
- Based on current prices, the company has particularly high valuation levels.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+14.56% | 232M | C- | ||
-29.70% | 3.14B | B- | ||
-18.39% | 2.46B | C+ | ||
+12.41% | 2.36B | - | A- | |
+41.48% | 2.77B | B | ||
-1.23% | 2.09B | - | ||
+40.00% | 2.14B | B | ||
+4.13% | 1.37B | - | ||
+48.11% | 1.49B | C | ||
+9.01% | 1.19B | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- BACTI B Stock
- Ratings Bactiguard Holding AB